Lomeguatrib

Overview

Lomeguatrib is a O 6 -methylguanine-DNA methyltransferase ( MGMT ) inhibitor, with IC 50 s of 9 nM in cell-free assay and ～6?nM in MCF-7 cells.

Application

Products | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > DNA Methyltransferase

Product Information

• Catalog No.: HY-13668
• CAS No.: 192441-08-0
• Molecular Formula: C10H8BrN5OS
• Molecular Weight: 326.17
• Purity: 99.77%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.08 mg/mL (6.38 mM); Clear solution
• Availability: In-stock

Source

Original product source